CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 25 filers reported holding CHAMPIONS ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,000 | – | 133 | +107.8% | 0.00% | – |
Q1 2024 | $0 | -100.0% | 64 | -70.9% | 0.00% | – |
Q4 2023 | $1,000 | – | 220 | +714.8% | 0.00% | – |
Q3 2023 | $0 | -100.0% | 27 | -88.1% | 0.00% | – |
Q2 2023 | $1,000 | -85.7% | 226 | -86.4% | 0.00% | – |
Q1 2023 | $7,000 | – | 1,666 | +1025.7% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 148 | -16.9% | 0.00% | – |
Q3 2022 | $2,000 | +100.0% | 178 | +78.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 100 | -20.0% | 0.00% | – |
Q3 2021 | $1,000 | -92.9% | 125 | -90.8% | 0.00% | – |
Q2 2021 | $14,000 | +75.0% | 1,354 | +79.1% | 0.00% | – |
Q1 2021 | $8,000 | +100.0% | 756 | +110.0% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 360 | +260.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 100 | -7.4% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 108 | -36.8% | 0.00% | – |
Q4 2019 | $2,000 | +100.0% | 171 | -2.8% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 176 | +76.0% | 0.00% | – |
Q2 2019 | $1,000 | – | 100 | +614.3% | 0.00% | – |
Q3 2018 | $0 | – | 14 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Battery Partners IX, LLC | 1,953,549 | $12,386,000 | 3.03% |
PERKINS CAPITAL MANAGEMENT INC | 103,000 | $653,000 | 0.47% |
NEA Management Company, LLC | 1,562,500 | $9,906,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 101,962 | $646,000 | 0.08% |
Granite Investment Partners, LLC | 139,698 | $886,000 | 0.06% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 114,951 | $729,000 | 0.01% |
Sandy Spring Bank | 8,333 | $53,000 | 0.01% |
Veritas Investment Management (UK) Ltd | 2,083 | $13,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,799 | $11,000 | 0.00% |
UBS Group AG | 1,590 | $10,000 | 0.00% |